Literature DB >> 21454568

Cholesteryl ester transfer protein expression partially attenuates the adverse effects of SR-BI receptor deficiency on cholesterol metabolism and atherosclerosis.

Majda El Bouhassani1, Sophie Gilibert, Martine Moreau, Flora Saint-Charles, Morgan Tréguier, Francesco Poti, M John Chapman, Wilfried Le Goff, Philippe Lesnik, Thierry Huby.   

Abstract

Scavenger receptor SR-BI significantly contributes to HDL cholesterol metabolism and atherogenesis in mice. However, the role of SR-BI may not be as pronounced in humans due to cholesteryl ester transfer protein (CETP) activity. To address the impact of CETP expression on the adverse effects associated with SR-BI deficiency, we cross-bred our SR-BI conditional knock-out mouse model with CETP transgenic mice. CETP almost completely restored the abnormal HDL-C distribution in SR-BI-deficient mice. However, it did not normalize the elevated plasma free to total cholesterol ratio characteristic of hepatic SR-BI deficiency. Red blood cell and platelet count abnormalities observed in mice liver deficient for SR-BI were partially restored by CETP, but the elevated erythrocyte cholesterol to phospholipid ratio remained unchanged. Complete deletion of SR-BI was associated with diminished adrenal cholesterol stores, whereas hepatic SR-BI deficiency resulted in a significant increase in adrenal gland cholesterol content. In both mouse models, CETP had no impact on adrenal cholesterol metabolism. In diet-induced atherosclerosis studies, hepatic SR-BI deficiency accelerated aortic lipid lesion formation in both CETP-expressing (4-fold) and non-CETP-expressing (8-fold) mice when compared with controls. Impaired macrophage to feces reverse cholesterol transport in mice deficient for SR-BI in liver, which was not corrected by CETP, most likely contributed by such an increase in atherosclerosis susceptibility. Finally, comparison of the atherosclerosis burden in SR-BI liver-deficient and fully deficient mice demonstrated that SR-BI exerted an atheroprotective activity in extra-hepatic tissues whether CETP was present or not. These findings support the contention that the SR-BI pathway contributes in unique ways to cholesterol metabolism and atherosclerosis susceptibility even in the presence of CETP.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21454568      PMCID: PMC3089565          DOI: 10.1074/jbc.M111.220483

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  43 in total

1.  CETP expression enhances liver HDL-cholesteryl ester uptake but does not alter VLDL and biliary lipid secretion.

Authors:  Lila M Harada; Ludwig Amigo; Patrícia M Cazita; Alessandro G Salerno; Attilio A Rigotti; Eder C R Quintão; Helena C F Oliveira
Journal:  Atherosclerosis       Date:  2006-06-27       Impact factor: 5.162

2.  Cholesteryl ester transfer protein (CETP) expression protects against diet induced atherosclerosis in SR-BI deficient mice.

Authors:  Christopher Harder; Paulina Lau; Andrew Meng; Stewart C Whitman; Ruth McPherson
Journal:  Arterioscler Thromb Vasc Biol       Date:  2007-02-01       Impact factor: 8.311

3.  Functional LCAT deficiency in human apolipoprotein A-I transgenic, SR-BI knockout mice.

Authors:  Ji-Young Lee; Robert M Badeau; Anny Mulya; Elena Boudyguina; Abraham K Gebre; Thomas L Smith; John S Parks
Journal:  J Lipid Res       Date:  2007-02-01       Impact factor: 5.922

4.  Hepatic scavenger receptor BI promotes rapid clearance of high density lipoprotein free cholesterol and its transport into bile.

Authors:  Y Ji; N Wang; R Ramakrishnan; E Sehayek; D Huszar; J L Breslow; A R Tall
Journal:  J Biol Chem       Date:  1999-11-19       Impact factor: 5.157

5.  Increased LDL cholesterol and atherosclerosis in LDL receptor-deficient mice with attenuated expression of scavenger receptor B1.

Authors:  D Huszar; M L Varban; F Rinninger; R Feeley; T Arai; V Fairchild-Huntress; M J Donovan; A R Tall
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-04       Impact factor: 8.311

6.  Secretion of apolipoprotein E from macrophages occurs via a protein kinase A and calcium-dependent pathway along the microtubule network.

Authors:  Maaike Kockx; Dongni Lily Guo; Thierry Huby; Philippe Lesnik; Jason Kay; Tharani Sabaretnam; Eve Jary; Michael Hill; Katharina Gaus; John Chapman; Jennifer L Stow; Wendy Jessup; Leonard Kritharides
Journal:  Circ Res       Date:  2007-07-27       Impact factor: 17.367

7.  Macrophage ABCA1 and ABCG1, but not SR-BI, promote macrophage reverse cholesterol transport in vivo.

Authors:  Xun Wang; Heidi L Collins; Mollie Ranalletta; Ilia V Fuki; Jeffrey T Billheimer; George H Rothblat; Alan R Tall; Daniel J Rader
Journal:  J Clin Invest       Date:  2007-08       Impact factor: 14.808

8.  Expression of cholesteryl ester transfer protein in mice promotes macrophage reverse cholesterol transport.

Authors:  Hiroyuki Tanigawa; Jeffrey T Billheimer; Jun-ichiro Tohyama; YuZhen Zhang; George Rothblat; Daniel J Rader
Journal:  Circulation       Date:  2007-08-20       Impact factor: 29.690

9.  CETP activity variation in mice does not affect two major HDL antiatherogenic properties: macrophage-specific reverse cholesterol transport and LDL antioxidant protection.

Authors:  Noemí Rotllan; Laura Calpe-Berdiel; Amy Guillaumet-Adkins; Songül Süren-Castillo; Francisco Blanco-Vaca; Joan Carles Escolà-Gil
Journal:  Atherosclerosis       Date:  2007-06-22       Impact factor: 5.162

10.  The effect of cholesteryl ester transfer protein overexpression and inhibition on reverse cholesterol transport.

Authors:  Urbain Tchoua; Wilissa D'Souza; Nigora Mukhamedova; Denise Blum; Eric Niesor; Jacques Mizrahi; Cyrille Maugeais; Dmitri Sviridov
Journal:  Cardiovasc Res       Date:  2007-12-04       Impact factor: 10.787

View more
  17 in total

1.  Impact of individual acute phase serum amyloid A isoforms on HDL metabolism in mice.

Authors:  Myung-Hee Kim; Maria C de Beer; Joanne M Wroblewski; Richard J Charnigo; Ailing Ji; Nancy R Webb; Frederick C de Beer; Deneys R van der Westhuyzen
Journal:  J Lipid Res       Date:  2016-03-27       Impact factor: 5.922

Review 2.  Cholesterol efflux and atheroprotection: advancing the concept of reverse cholesterol transport.

Authors:  Robert S Rosenson; H Bryan Brewer; W Sean Davidson; Zahi A Fayad; Valentin Fuster; James Goldstein; Marc Hellerstein; Xian-Cheng Jiang; Michael C Phillips; Daniel J Rader; Alan T Remaley; George H Rothblat; Alan R Tall; Laurent Yvan-Charvet
Journal:  Circulation       Date:  2012-04-17       Impact factor: 29.690

3.  Increased plasma cholesterol esterification by LCAT reduces diet-induced atherosclerosis in SR-BI knockout mice.

Authors:  Seth G Thacker; Xavier Rousset; Safiya Esmail; Abdalrahman Zarzour; Xueting Jin; Heidi L Collins; Maureen Sampson; John Stonik; Stephen Demosky; Daniela A Malide; Lita Freeman; Boris L Vaisman; Howard S Kruth; Steven J Adelman; Alan T Remaley
Journal:  J Lipid Res       Date:  2015-05-11       Impact factor: 5.922

4.  Cholesteryl ester transfer protein protects against insulin resistance in obese female mice.

Authors:  David A Cappel; Brian T Palmisano; Christopher H Emfinger; Melissa N Martinez; Owen P McGuinness; John M Stafford
Journal:  Mol Metab       Date:  2013-09-02       Impact factor: 7.422

Review 5.  Functional genomics of the human high-density lipoprotein receptor scavenger receptor BI: an old dog with new tricks.

Authors:  Alexandra C Chadwick; Daisy Sahoo
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2013-04       Impact factor: 3.243

Review 6.  Lecithin:cholesterol acyltransferase: old friend or foe in atherosclerosis?

Authors:  Sandra Kunnen; Miranda Van Eck
Journal:  J Lipid Res       Date:  2012-05-07       Impact factor: 5.922

7.  Macrophage SR-BI regulates LPS-induced pro-inflammatory signaling in mice and isolated macrophages.

Authors:  Lei Cai; Zhen Wang; Jason M Meyer; Ailing Ji; Deneys R van der Westhuyzen
Journal:  J Lipid Res       Date:  2012-05-15       Impact factor: 5.922

8.  Inhibition of hepatic scavenger receptor-class B type I by RNA interference decreases atherosclerosis in rabbits.

Authors:  Egon Demetz; Ivan Tancevski; Kristina Duwensee; Ursula Stanzl; Eva Huber; Christiane Heim; Florian Handle; Markus Theurl; Andrea Schroll; Anne Tailleux; Hermann Dietrich; Josef R Patsch; Philipp Eller; Andreas Ritsch
Journal:  Atherosclerosis       Date:  2012-03-23       Impact factor: 5.162

9.  Prolonged restraint stress increases IL-6, reduces IL-10, and causes persistent depressive-like behavior that is reversed by recombinant IL-10.

Authors:  Jeffrey L Voorhees; Andrew J Tarr; Eric S Wohleb; Jonathan P Godbout; Xiaokui Mo; John F Sheridan; Timothy D Eubank; Clay B Marsh
Journal:  PLoS One       Date:  2013-03-08       Impact factor: 3.240

10.  HDL, Atherosclerosis, and Emerging Therapies.

Authors:  Anouar Hafiane; Jacques Genest
Journal:  Cholesterol       Date:  2013-05-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.